These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 16444604)
1. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. Shams'ili S; de Beukelaar J; Gratama JW; Hooijkaas H; van den Bent M; van 't Veer M; Sillevis Smitt P J Neurol; 2006 Jan; 253(1):16-20. PubMed ID: 16444604 [TBL] [Abstract][Full Text] [Related]
2. A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes. de Jongste AH; van Gelder T; Bromberg JE; de Graaf MT; Gratama JW; Schreurs MW; Hooijkaas H; Sillevis Smitt PA Neuro Oncol; 2015 Jan; 17(1):145-50. PubMed ID: 24994790 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes. Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485 [TBL] [Abstract][Full Text] [Related]
4. Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction. Coret F; Bosca I; Fratalia L; Perez-Griera J; Pascual A; Casanova B J Neurooncol; 2009 Jul; 93(3):421-3. PubMed ID: 19139820 [TBL] [Abstract][Full Text] [Related]
5. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected. Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848 [TBL] [Abstract][Full Text] [Related]
6. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes. Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889 [TBL] [Abstract][Full Text] [Related]
8. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer. Douglas CA; Ellershaw J Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156 [TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes. van Broekhoven F; de Graaf MT; Bromberg JE; Hooijkaas H; van den Bent MJ; de Beukelaar JW; Khan NA; Gratama JW; van der Geest JN; Frens M; Benner R; Sillevis Smitt PA J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1341-4. PubMed ID: 20667866 [TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of paraneoplastic neurological syndromes]. Tanaka K Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170 [TBL] [Abstract][Full Text] [Related]
11. Tumor progression and serum anti-HuD antibody concentration in patients with paraneoplastic neurological syndromes. Rauer S; Andreou I Eur Neurol; 2002; 47(4):189-95. PubMed ID: 12037430 [TBL] [Abstract][Full Text] [Related]
12. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values. Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927 [TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies in Paraneoplastic Neurological Syndrome]. Kawachi I Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281 [TBL] [Abstract][Full Text] [Related]
15. Effects of antineuronal antibodies from patients with paraneoplastic neurological syndrome on primary-cultured neurons. Tanaka K; Ding X; Tanaka M J Neurol Sci; 2004 Jan; 217(1):25-30. PubMed ID: 14675605 [TBL] [Abstract][Full Text] [Related]
16. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms. Rauer S; Czygan M; Kaiser R J Neurol; 2002 Mar; 249(3):285-9. PubMed ID: 11993527 [TBL] [Abstract][Full Text] [Related]